{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:41:05Z","timestamp":1773423665472,"version":"3.50.1"},"reference-count":10,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2344,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/j.1365-2710.2008.00996.x","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T13:54:59Z","timestamp":1227794099000},"page":"245-246","source":"Crossref","is-referenced-by-count":23,"title":["Aripiprazole in combination with other antipsychotic drugs may worsen psychosis"],"prefix":"10.1155","volume":"34","author":[{"given":"J.","family":"Adan-Manes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Garcia-Parajua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmachology, clinical efficacy and tolerability","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clinical Therapeutics"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/13543784.16.6.771","article-title":"Aripiprazole acts as a selective dopamine D2 receptor partial agonist","volume":"16","author":"Wood","year":"2007","journal-title":"Expert Opinion Investigational Drugs"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Kane","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4088\/JCP.v65n0122b","article-title":"Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?","volume":"65","author":"DeQuardo","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1176\/appi.ajp.161.7.1308","article-title":"Worsening schizoaffective disorder with aripiprazole","volume":"161","author":"Reeves","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004850-200401000-00009","article-title":"Aripiprazole possibly worsens psychosis","volume":"19","author":"Ramaswamy","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.4088\/JCP.v66n1019h","article-title":"Treatment-emergent psychosis with aripiprazole","volume":"66","author":"Barnas","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4088\/JCP.v68n0522h","article-title":"Aripiprazole and worsening of psychosis: a case report","volume":"68","author":"Ahuja","year":"2007","journal-title":"Journal of Clinical Psychistry"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.2006.00787.x","article-title":"Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse","volume":"114","author":"Moncrieff","year":"2006","journal-title":"Acta Psychiatric Scandinavica"},{"key":"10.1111\/j.1365-2710.2008.00996.x-BIB10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.pnpbp.2003.09.006","article-title":"Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality","volume":"27","author":"M\u00f6ller","year":"2003","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2008.00996.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2008.00996.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:49Z","timestamp":1671818569000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2008.00996.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00996.x","relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}